Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Anteris Technologies Global Corp. (AVR) vs LeMaitre Vascular, Inc. (LMAT)

Anteris Technologies Global Corp. and LeMaitre Vascular, Inc. are both Medical Instruments & Supplies companies. LeMaitre Vascular, Inc. is the larger, with a market value of $1.9B against $745.6M — 2.5× the size. Anteris Technologies Global Corp. has negative trailing earnings, so its P/E is not meaningful; LeMaitre Vascular, Inc. trades at 28.1×. LeMaitre Vascular, Inc. grew revenue faster over the last twelve months: 11.9% against −9.56%. LeMaitre Vascular, Inc. has the higher net margin (25.0% vs −4,619.3%) and the higher return on invested capital (22.7% vs 0.00%). Across the 17 metrics below, LeMaitre Vascular, Inc. leads on 13 and Anteris Technologies Global Corp. on 4.

Valuation

Metric AVR LMAT Medical Instruments & Supplies median
P/E n/m 28.11 34.17
P/S 333.87 7.10 2.83
P/B 2.97 4.43 2.82
Price to free cash flow n/m 25.25 25.69
EV/EBITDA n/m 18.70 16.08
EV/Sales 219.27 6.32 3.06
Earnings yield (25.36%) 3.56% (1.84%)
Free cash flow yield (11.79%) 3.96% 0.17%

Profitability

Metric AVR LMAT Medical Instruments & Supplies median
Gross margin 74.98% 72.90% 54.62%
Operating margin (4,738.36%) 29.46% 1.64%
Net margin (4,619.27%) 25.02% 0.00%
Free cash flow margin (3,937.07%) 28.13% 1.61%
Return on equity (75.13%) 16.77% 0.00%
Return on assets (66.31%) 10.78% 0.00%
Return on invested capital 0.00% 22.67% 0.00%

Growth

Metric AVR LMAT Medical Instruments & Supplies median
Revenue growth (TTM) (9.56%) 11.85% 9.20%
EPS growth (last fiscal year) 30.71% 30.57% —
Revenue growth, 5-year CAGR — 14.05% 9.48%
Net income growth, 5-year CAGR — 22.16% 0.00%

Health

Metric AVR LMAT Medical Instruments & Supplies median
Debt to equity 0.00 0.40 0.08
Current ratio 14.20 16.31 2.49
Net debt to EBITDA 0.14 (2.40) 0.83

Dividend

Metric AVR LMAT Medical Instruments & Supplies median
Dividend yield — 0.92% 0.99%
Payout ratio — 0.47 0.00

Size

Metric AVR LMAT Medical Instruments & Supplies median
Market cap 745.56m 1.85b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack